|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$412,354
|
$82,471
|
Hickstein, Dennis
|
CCR (NCI)
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-06S1
|
$74,858
|
$749
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-06
|
$1,560,000
|
$15,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer
|
5R01CA044722-24
|
$216,873
|
$108,437
|
STUDZINSKI, GEORGE
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
|
Validation and Development of WEE1 as a therapeutic target in AML
|
5R01CA172385-02
|
$305,619
|
$152,810
|
PORTER, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Validating Syk as a Target for AML Therapy
|
2R01CA140292-06
|
$387,775
|
$387,775
|
STEGMAIER, KIMBERLY
|
DANA-FARBER CANCER INST
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S1
|
$75,000
|
$3,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S2
|
$4,154
|
$166
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S3
|
$12,487
|
$499
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-39S4
|
$126,993
|
$5,080
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$242,850
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Unleashing the Efficacy of PI3K/AKT/mTOR Pathway Inhibitors in B-ALL
|
1F32CA189629-01
|
$53,282
|
$53,282
|
VO, THANH-TRANG
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S1
|
$75,000
|
$23,250
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S2
|
$113,250
|
$35,108
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S3
|
$125,000
|
$38,750
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-10S4
|
$50,000
|
$15,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-10
|
$1,876,081
|
$581,585
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-05
|
$327,998
|
$327,998
|
BAKER, SHARYN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$358,240
|
$35,824
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
|
Tsc1/mTOR axis in immune homeostasis and tumorigenesis
|
1R01CA176624-01A1
|
$369,350
|
$369,350
|
CHI, HONGBO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Transponson-based screens for genes involved in acute lymphoblastic Leukemia
|
5R01CA154998-04
|
$286,395
|
$143,198
|
FARRAR, MICHAEL
|
UNIVERSITY OF MINNESOTA
|
|
|
Transcriptional regulatory mechanisms in B cell development and leukemogenesis
|
5R01CA178765-02
|
$548,492
|
$548,492
|
ROEDER, ROBERT
|
ROCKEFELLER UNIVERSITY
|
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-03
|
$397,781
|
$397,781
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-02
|
$308,958
|
$308,958
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
|
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
|
1U01CA183030-01
|
$653,666
|
$653,666
|
LIU, YANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
5R01CA155743-04
|
$322,040
|
$322,040
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of HO-1 in Flt3-ITD positive AML proliferation and drug resistance
|
5F32CA171905-02
|
$53,282
|
$26,641
|
IRWIN, MARY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
The Role of FBXL4 in T-cell Acute Lymphoblastic Leukemia
|
5F30CA174099-02
|
$42,273
|
$21,137
|
HAYDU, JULIE-ERIKA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of ETV6 in T-cell acute lymphoblastic leukemia
|
5R01CA172398-02
|
$322,040
|
$161,020
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of CD4+ T Cells in Oncogene Addiction
|
5F32CA177139-02
|
$53,282
|
$53,282
|
CASEY, STEPHANIE
|
STANFORD UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-19S3
|
$21,615
|
$432
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S1
|
$75,000
|
$1,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S2
|
$50,000
|
$1,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-20S3
|
$77,097
|
$1,542
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$93,723
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Requirement for Trib2 in the Maintenance of Acute Myeloid Leukemia
|
5F31CA165813-03
|
$29,130
|
$29,130
|
BAILIS, WILL
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
The pluripotency regulator Prdm14 initiates cancer by epigenetic mechanisms
|
7R01CA163849-02
|
$319,918
|
$159,959
|
JUSTICE, MONICA
|
HOSPITAL FOR SICK CHLDRN (TORONTO)
|
|
|
The Impact of Treatment Adherence on A Clinical Biomarker in Pediatric Acute Lymp
|
5F31CA168307-02
|
$14,355
|
$14,355
|
ROHAN, JENNIFER
|
UNIVERSITY OF CINCINNATI
|
|
|
The contribution of protein translation to tumorigenesis
|
5R01CA142798-05
|
$370,951
|
$92,738
|
WENDEL, HANS-GUIDO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
The COMPASS family of H3K4 methylases in development and cancer
|
2R01CA150265-06
|
$261,777
|
$261,777
|
SHILATIFARD, ALI
|
STOWERS INSTITUTE FOR MEDICAL RESEARCH
|
|
|
Temporal and Spatial Control of V(D)J Recombination
|
3R01CA160256-03S1
|
$51,299
|
$51,299
|
DESIDERIO, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Temporal and Spatial Control of V(D)J Recombination
|
5R01CA160256-03
|
$326,066
|
$326,066
|
DESIDERIO, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Targeting to Epigenetic Modications in ALL
|
5R01CA176745-04
|
$390,183
|
$390,183
|
ARMSTRONG, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Targeting the Core Binding Factor tumor suppressor in MLL-fusion AML
|
1R43CA176907-01A1
|
$224,629
|
$112,315
|
GEIGER, HARTMUT
|
P2D, INC.
|
|
|
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
|
5R01CA154471-04
|
$322,040
|
$322,040
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
5U01CA151837-05
|
$417,323
|
$417,323
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Targeting non-classical oncogenes as therapy for T-ALL
|
5R01CA169162-03
|
$322,040
|
$161,020
|
DIACOVO, THOMAS
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Targeting Leukemia Stem Cells with Dietary Selenium
|
5R01CA162665-03
|
$294,125
|
$294,125
|
PRABHU, KUMBLE SANDEEP
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
|
Targeting Chromatin Modifications in Leukemia with Trisomy 21
|
1K08CA181340-01
|
$155,991
|
$77,996
|
LANE, ANDREW
|
DANA-FARBER CANCER INST
|
|
|
Targeting BCL6 in tyrosine kinase-driven leukemia
|
5R01CA169458-02
|
$317,679
|
$158,840
|
MUSCHEN, MARKUS
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Total relevant funding to Childhood Leukemia for this search: $55,209,492
|
